VivoSim Labs
VIVS
VivoSim Labs (VIVS) news
Recent news
Vivosim Labs - announces $4 mln private placement at $0.85 per share
AInvest Wire · Jul 16, 2026Vivosim sees FY2027 revenue growth of 500%+
AInvest Wire · Jul 15, 2026ImportantVivosim Labs - eligible for up to $45 mln in additional milestone payments from Eli Lilly
Vivosim Labs received a $5M milestone payment from Eli Lilly on July 15, 2026, and has provided guidance expecting over 500% revenue growth in FY2027, while remaining eligible for up to $45 million in additional milestone payments from Eli Lilly; reported by authoritative news sources.
AInvest Wire · Jul 15, 2026ImportantVivosim receives $5M milestone payment from Eli Lilly; provides guidance that it expects revenue growth of 500%+ in FY2027
AInvest Wire · Jul 15, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.